Pneumonia (peds)
This page is for pediatric patients. For adult patients, see: pneumonia
Background
- Most common site of infection in neonates
Bugs by Age Group
- Newborn
- 1-3 months
- 3 months-5 years
- S. pneumoniae
- S. aureus
- H. influenzae type b
- Nontypeable H. influenzae
- C. trachomatis
- Mycoplasma pneumoniae
- 5–18 years
Clinical Features
Fever and tachypnea are sensitive but not specific
Differential Diagnosis
Pediatric fever
- Upper respiratory infection (URI)
- UTI
- Sepsis
- Meningitis
- Febrile seizure
- Pneumonia
- Acute otitis media
- Whooping cough
- Unclear source
- Kawasaki disease
- Neonatal HSV
- Specific virus
Pediatric Shortness of Breath
Pulmonary/airway
- Airway obstruction
- Structural
- Infectious
- Other
Cardiac
- Congenital heart disease
- Vascular ring
- Cardiac tamponade
- Congestive Heart Failure (peds)
- Myocarditis (peds)
Other diseases with abnormal respiration
- Normal neonatal periodic breathing (misinterpreted by caregivers as abnormal)
- Brief resolved unexplained event
- Anemia
- Abdominal distension (e.g. SBO, liver failure
- Neonatal abstinence syndrome
- Decreased perfusion states
- Metabolic acidosis
- CO Poisoning
- Diaphragm injury
- Renal Failure
- Electrolyte abnormalities
- Organophosphate toxicity
- Tick paralysis
- Fever (Peds)
- Panic attack
- Porphyria
Evaluation
- Absence of tachypnea, respiratory distress, and rales/decreased breath sounds rules-out with 100% sensitivity
- Imaging
- CXR is not the gold standard!
- Cannot differentiate between viral and bacterial (but lobar infiltrate more often bacterial)
- Consider for:
- Age 0-3mo (as part of sepsis workup)
- <5yr with temperature >102.2, WBC >20K and no clear source of infection
- Ambiguous clinical findings
- Pneumonia that is prolonged or not responsive to antibiotics
- Consider rapid assays for RSV, influenza
- Blood/nasal culture are low yield
- in prospective study, 91 blood cultures needed for one positive result for CAP; but in ICU one child had bacteremia for every 24 cultures obtained, one for every 12 with parapneumonic effusion [1]
- consider for sicker ones, those with effusions
Treatment[2]
Newborn
- Hospitalized
- Ampicillin (80-90mg/kg/day) + gentamicin +/- cefotaxime
- Add vancomycin if MRSA a concern
- Add erythromycin (12.g mg/kg QID) if concern for chlamydia
- Ampicillin (80-90mg/kg/day) + gentamicin +/- cefotaxime
- Outpatient
- Initial outpatient management not recommended
1-3 Month
- Hospitalized
- Afebrile pneumonitis
- Erythromycin (10 mg/kg q6) or Azithromycin (2.5 mg/kg q12)
- Febrile pneumonia
- Add Cefotaxime (200mg/kg per day divided q8h)
- Afebrile pneumonitis
- Outpatient
- Erythromycin OR Azithromycin PO
>3mo - 18 years
- Hospitalized (PICU/severely ill)
- Ceftriaxone IV AND Vancomycin AND consider Azithromycin
- Hospitalized (moderately ill)
- Fully immunized: Ampicillin (50mg/kg q6) IV
- Not fully immunized: Ceftriaxone IV
- Outpatient
- Amoxicillin (90 mg/kg divided BID) x 10 days PO
- Some studies have shown that 5 day course may also be adequate treatment
- Alternative: Clindamycin OR Azithromycin OR Amoxicillin-clavulanate
- Amoxicillin (90 mg/kg divided BID) x 10 days PO
Disposition
All Children less than 2 months should be hospitalized[3]
Consider Admission For
- Age: <2-3 months old
- History of severe or relevant congenital disorders
- Immune suppression (HIV, SCD, malignancy)
- Toxic appearance/respiratory distress
- SpO2 <90-93%
- Vomiting/dehydration
- Unstable social environment